Lv1
40 积分 2025-03-07 加入
Establishing a common metric for physical function: Linking SARC-F and PROMIS® physical function
7个月前
已关闭
Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
7个月前
已完结
Advancements of investigational agents for cancer cachexia: what clinical progress have we seen in the last 5 years?
8个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
9个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
11个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
11个月前
已完结
Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system
11个月前
已完结
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
1年前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
1年前
已完结
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer
1年前
已完结
皖公网安备34019202002308
